CS236488B2 - Method of new suphimines production - Google Patents

Method of new suphimines production Download PDF

Info

Publication number
CS236488B2
CS236488B2 CS825591A CS559182A CS236488B2 CS 236488 B2 CS236488 B2 CS 236488B2 CS 825591 A CS825591 A CS 825591A CS 559182 A CS559182 A CS 559182A CS 236488 B2 CS236488 B2 CS 236488B2
Authority
CS
Czechoslovakia
Prior art keywords
butoxy
title compound
prepared
theory
group
Prior art date
Application number
CS825591A
Other languages
Czech (cs)
English (en)
Inventor
Erich Mueller
Josef Nickl
Berthold Narr
Josef Roch
Walter Haarmann
Johanes Weisenberger
Original Assignee
Thomae Gmbh Dr K
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thomae Gmbh Dr K filed Critical Thomae Gmbh Dr K
Publication of CS236488B2 publication Critical patent/CS236488B2/cs

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/22—Oxygen atoms attached in position 2 or 4
    • C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32—Oxygen atoms
    • C07D209/34—Oxygen atoms in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Indole Compounds (AREA)
CS825591A 1981-07-25 1982-07-22 Method of new suphimines production CS236488B2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19813129444 DE3129444A1 (de) 1981-07-25 1981-07-25 "sulfoximine, deren herstellung und diese verbindungen enthaltende arzneimittel"

Publications (1)

Publication Number Publication Date
CS236488B2 true CS236488B2 (en) 1985-05-15

Family

ID=6137766

Family Applications (1)

Application Number Title Priority Date Filing Date
CS825591A CS236488B2 (en) 1981-07-25 1982-07-22 Method of new suphimines production

Country Status (19)

Country Link
JP (1) JPS5824559A (da)
KR (1) KR840000491A (da)
AR (1) AR230745A1 (da)
AU (1) AU556082B2 (da)
CA (1) CA1175430A (da)
CS (1) CS236488B2 (da)
DD (1) DD202871A5 (da)
DE (2) DE3129444A1 (da)
DK (1) DK329582A (da)
ES (4) ES514275A0 (da)
FI (1) FI822550A7 (da)
GR (1) GR76181B (da)
HU (1) HU188188B (da)
NO (1) NO822255L (da)
PL (1) PL137725B1 (da)
PT (1) PT75297A (da)
SU (1) SU1158041A3 (da)
YU (1) YU158182A (da)
ZA (1) ZA825273B (da)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7863283B2 (en) * 2008-01-17 2011-01-04 Bayer Schering Pharma Ag Sulphoximine-substituted quinazoline derivatives as immuno-modulators, their preparation and use as medicaments

Also Published As

Publication number Publication date
DE3246980A1 (de) 1984-06-20
ES518828A0 (es) 1983-10-16
CA1175430A (en) 1984-10-02
AU556082B2 (en) 1986-10-23
FI822550L (fi) 1983-01-26
GR76181B (da) 1984-08-03
SU1158041A3 (ru) 1985-05-23
AU8637882A (en) 1983-04-14
ES8400411A1 (es) 1983-10-16
KR840000491A (ko) 1984-02-22
ZA825273B (en) 1984-03-28
ES518826A0 (es) 1983-10-16
AR230745A1 (es) 1984-06-29
DD202871A5 (de) 1983-10-05
ES8400410A1 (es) 1983-10-16
NO822255L (no) 1983-01-26
PT75297A (fr) 1982-08-01
YU158182A (en) 1984-08-31
JPS5824559A (ja) 1983-02-14
ES8305333A1 (es) 1983-04-01
ES514275A0 (es) 1983-04-01
FI822550A0 (fi) 1982-07-20
DK329582A (da) 1983-01-26
FI822550A7 (fi) 1983-01-26
PL237600A1 (en) 1983-03-28
HU188188B (en) 1986-03-28
ES518827A0 (es) 1983-10-16
ES8400412A1 (es) 1983-10-16
DE3129444A1 (de) 1983-02-10
PL137725B1 (en) 1986-07-31

Similar Documents

Publication Publication Date Title
EP3154941B1 (en) Small molecule lfa-1 inhibitors
JP2695852B2 (ja) 薬剤組成物
NO136595B (da)
KR100232324B1 (ko) 허혈성 질환을 예방 및 치료하기 위한 트로폴론 유도체 및 그의 약학 조성물
US4629733A (en) Indolinones and pharmaceutical compositions containing same
US4889866A (en) Arylsulfonyl dihydropyridine derivatives
FI79704C (fi) Foerfarande foer framstaellning av benzoxazin-2-oner.
US4696937A (en) Thiosulfonate derivatives for inhibiting malformation or destruction of red blood corpuscules
EP0071150B1 (de) Sulfimine, deren Salze und deren Herstellung sowie diese Verbindungen enthaltende Arzneimittel
NO142403B (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive isokinoliner
SU1158041A3 (ru) Способ получени производных сульфимина
US2484489A (en) 3, 4-dichlorophenylsulfonyl tribromomethane
CS227005B2 (en) Method of preparing carbostyrile and oxindol derivatives
US3133933A (en) Certain
EP0310648B1 (en) Condensation products of 2,2,4-trimethyl-1,2-dihydro-quinoline and oxo compounds and derivatives thereof
JPS6411015B2 (da)
RU2671983C1 (ru) Антиокоагулянтное средство непрямого действия на основе диуманкала
DE3143327A1 (de) "neue indolinone, ihre herstellung und ihre verwendung als arzneimittel"
RU2030408C1 (ru) Производные оксазола
Hendess 1, 4-Benzoxazines. Conversion to a benzoxazole and an indolo [3, 2-b][1, 4] benzoxazine
DE3142904A1 (de) Arzneimittel zur vermeidung von tumormetasierung
JPS59104378A (ja) カルボスチリル誘導体
HK1157325A (en) 5-(4-methanesulfonyl-phenyl)-thiazole derivatives for the treatment of acute and chronic inflammatory diseases
SI8010849A8 (sl) Postopek za pridobivanje 3-(metiltio, metilsulfinil ali metilsulfonil)-4-kinolonov
CS235176B1 (cs) Substituované 4-fenoxy-3-methyl-llí-pýtaždlo(3j4-b)chinoliny a způsoby jejich přípravy